Literature DB >> 3122815

The soluble interleukin-2 receptor in haematological disorders.

G Pizzolo1, M Chilosi, G Semenzato.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3122815     DOI： 10.1111/j.1365-2141.1987.tb06156.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  16 in total

1.  Relations between surface expression of the interleukin-2 receptor and release of the soluble form of the receptor in cultured mononuclear cells from patients with rheumatoid arthritis or systemic lupus erythematosus.

Authors:  M Itoh; Y Goto; Y Ohta; Y Goto; H Ohashi
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

2.  Longitudinal survey in an endemic region of plasma soluble interleukin-2 receptor and antibody levels in Plasmodium falciparum malaria.

Authors:  B F Chumpitazi; F Peyron; J Simon; C Boudin; I Sheick-Zakiuddin; S Picot; P Ambroise-Thomas
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

3.  Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  G Semenzato; L M Bambara; D Biasi; A Frigo; F Vinante; B Zuppini; L Trentin; C Feruglio; M Chilosi; G Pizzolo
Journal:  J Clin Immunol       Date:  1988-11       Impact factor: 8.317

Review 4.  Silica exposure and altered regulation of autoimmunity.

Authors:  Suni Lee; Hidenori Matsuzaki; Naoko Kumagai-Takei; Kei Yoshitome; Megumi Maeda; Ying Chen; Masayasu Kusaka; Kozo Urakami; Hiroaki Hayashi; Wataru Fujimoto; Yasumitsu Nishimura; Takemi Otsuki
Journal:  Environ Health Prev Med       Date:  2014-08-19       Impact factor: 3.674

5.  A disturbance of the IL-2/IL-2 receptor system parallels the activity of multiple myeloma.

Authors:  A Vacca; R Di Stefano; A Frassanito; G Iodice; F Dammacco
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

6.  LW/SO cell line: a tool for studying the phenotypical characterization and commitment of hematopoietic stem cells.

Authors:  S Oez; U Trautmann; M Smetak; J Birkmann; S al salemeh; E Gebhart; W M Gallmeier
Journal:  Ann Hematol       Date:  1996-05       Impact factor: 3.673

7.  Diagnosis of a previously unidentified primary site in patients with spinal metastasis: diagnostic usefulness of laboratory analysis, CT scanning and CT-guided biopsy.

Authors:  Yoichi Iizuka; Haku Iizuka; Satoshi Tsutsumi; Yumi Nakagawa; Takashi Nakajima; Yasunori Sorimachi; Tsuyoshi Ara; Masahiro Nishinome; Takayuki Seki; Kenji Takagishi
Journal:  Eur Spine J       Date:  2009-06-16       Impact factor: 3.134

8.  Standardized uptake value on FDG-PET as a marker for disease activity in patients with non-Hodgkin's lymphoma: comparison with serum soluble interleukin-2 receptor values.

Authors:  Mitsuaki Tatsumi; Hiroyuki Sugahara; Ichiro Higuchi; Hiroki Fukunaga; Hironobu Nakamura; Yuzuru Kanakura; Jun Hatazawa
Journal:  Int J Clin Oncol       Date:  2009-04-24       Impact factor: 3.402

9.  Lymphocyte activation in patients with acute myeloid leukaemia. Evidence for the presence of myeloblast antigen?

Authors:  S H Lim; C P Worman; A H Goldstone
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

10.  Soluble interleukin-2 receptor and soluble CD8 antigen levels in serum from patients with non-resectable lung cancer.

Authors:  J Vibe-Petersen; N Tvede; M Diamant; A A Kjerulff; H R Sørensen; V Andersen
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.